El-Naggar AK, Chan JKC, Rubin Grandis J, Takata T, Slootweg PJ, International Agency for Research on C. Who classification of head and neck tumours. Lyon: International Agency for Research on Cancer; 2017.
Kass JI, Lee SC, Abberbock S, Seethala RR, Duvvuri U. Adenosquamous carcinoma of the head and neck: molecular analysis using <scp>CRTC</scp>-<scp>MAML FISH</scp> and survival comparison with paired conventional squamous cell carcinoma. Laryngoscope. 2015;125:E371–6.
Article PubMed CAS Google Scholar
Masand RP, El-Mofty SK, Ma X-J, Luo Y, Flanagan JJ, Lewis JS. Adenosquamous carcinoma of the head and neck: relationship to human papillomavirus and review of the literature. Head Neck Pathol. 2011;5:108–16.
Article PubMed PubMed Central Google Scholar
Lee RJ, Lin T, Lee SA, Lee KK, Christensen RE. Importance of tumor extent in adenosquamous carcinoma of the head and neck: a retrospective cohort study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;124:114–20.
Alos L, Castillo M, Nadal A, et al. Adenosquamous carcinoma of the head and neck: criteria for diagnosis in a study of 12 cases. Histopathology. 2004;44:570–9.
Article PubMed CAS Google Scholar
Fonseca FP, Ramos LMA, Vargas PA, De Almeida OP, Lopes MA, Santos‐Silva AR. Oral adenosquamous carcinoma: evidence that it arises from the surface mucosal epithelium. Histopathology. 2012;61:321–3.
Dubal PM, Unsal AA, Echanique KA, et al. Laryngeal adenosquamous carcinoma: a population-based perspective. Laryngoscope. 2016;126:858–63.
Mehrad M, Trinkaus K, Lewis JS. Adenosquamous carcinoma of the head and neck: a case-control study with conventional squamous cell carcinoma. Head Neck Pathol. 2016;10:486–93.
Article PubMed PubMed Central Google Scholar
Talevich E, Shain AH, Botton T, Bastian BC. CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing. PLoS Comput Biol. 2016;12:e1004873.
Article PubMed PubMed Central Google Scholar
Chalmers ZR, Connelly CF, Fabrizio D, et al. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med. 2017. https://doi.org/10.1186/s13073-017-0424-2.
Article PubMed PubMed Central Google Scholar
Cancer Genome Atlas N. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015;517:576–82.
Mikula M, Schreiber M, Husak Z, et al. Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene. EMBO J. 2001;20:1952–62.
Article PubMed PubMed Central CAS Google Scholar
Liao Y, Satoh T, Gao X, Jin T-G, Hu C-D, Kataoka T. RA-GEF-1, a guanine nucleotide exchange factor for Rap 1, is activated by translocation induced by association with Rap1·GTP and enhances Rap1-dependent B-Raf activation. J Biol Chem. 2001;276:28478–83.
Article PubMed CAS Google Scholar
Weber A, Langhanki L, Sommerer F, Markwarth A, Wittekind C, Tannapfel A. Mutations of the BRAF gene in squamous cell carcinoma of the head and neck. Oncogene. 2003;22:4757–9.
Article PubMed CAS Google Scholar
Guaitoli G, Zullo L, Tiseo M, Dankner M, Rose AA, Facchinetti F. Non-small-cell lung cancer: how to manage BRAF-mutated disease. Drugs Context. 2023;12:1–19.
Mazieres J, Cropet C, Montané L, et al. Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations. Ann Oncol. 2020;31:289–94.
Comments (0)